Case Report: Severe psoriasis skin lesions following ofatumumab treatment for multiple sclerosis by Wioletta Katarzyna Żukowicz-Wyrwa, Wioletta Katarzyna Żukowicz-Wyrwa, Karolina Markiet, Karolina Markiet, Tatsiana Damps, Tatsiana Damps, Aleksandra Ciarka, Bartosz Karaszewski, Bartosz Karaszewski, Roman Nowicki, Roman Nowicki

Subjects: Get full text

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression by Oanh T. P. Nguyen, Sandra Lara, Giovanni Ferro, Matthias Peipp, Sandra Kleinau

Subjects: “…anti-CD20 antibody…”
Get full text

Early relapse during B lymphocyte depletion of children with frequently relapse /steroid dependent nephrotic syndrome after rituximab treatment by Juan Tu, Ling Wan, Huarong Li, Chaoying Chen

Subjects: “…Monoclonal anti-CD20 antibody…”
Get full text

Persistent SARS-CoV-2 infection resolved after B-cell recovery in a patient with follicular lymphoma treated with B-cell depletion therapy by Yuriko Sueda, Hirokazu Tokuyasu, Momoka Atsuta, Hiromitsu Sakai, Katsunori Arai, Chika Esumi, Misato Mochizuki, Tomoki Itohara, Naoki Fujisawa, Akira Yamasaki

Subjects: “…Anti-CD20 antibody…”
Get full text

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany by Mathias Buttmann, Martin S. Weber, Martin S. Weber, Sven G. Meuth, Sandra Blümich, Stefanie Hieke-Schulz, Petra Dirks, Julius C. Eggebrecht, Tjalf Ziemssen

Subjects: “…humanized monoclonal anti-CD20 antibody…”
Get full text

Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra by K. A. Sychevskaya, S. K. Kravchenko

Subjects: “…monoclonal anti-cd20 antibody…”
Get full text